KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 73 filers reported holding KINNATE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,650,900 | +2.5% | 4,264,144 | 0.0% | 0.60% | +14.2% |
| Q4 2022 | $26,011,278 | -49.0% | 4,264,144 | 0.0% | 0.53% | -51.4% |
| Q3 2022 | $50,956,000 | -5.2% | 4,264,144 | 0.0% | 1.09% | -24.2% |
| Q2 2022 | $53,771,000 | +12.0% | 4,264,144 | 0.0% | 1.43% | +36.8% |
| Q1 2022 | $48,014,000 | -24.6% | 4,264,144 | +18.7% | 1.05% | -6.7% |
| Q4 2021 | $63,669,000 | -23.0% | 3,593,052 | 0.0% | 1.12% | -2.0% |
| Q3 2021 | $82,712,000 | -1.1% | 3,593,052 | 0.0% | 1.15% | -14.7% |
| Q2 2021 | $83,646,000 | -25.3% | 3,593,052 | 0.0% | 1.34% | -20.4% |
| Q1 2021 | $111,960,000 | -21.7% | 3,593,052 | 0.0% | 1.69% | -15.5% |
| Q4 2020 | $142,932,000 | – | 3,593,052 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $60,447,769 | 31.36% |
| Vida Ventures Advisors, LLC | 2,207,772 | $13,798,575 | 18.88% |
| Lynx1 Capital Management LP | 2,214,250 | $13,839,063 | 11.54% |
| Foresite Capital Management V, LLC | 1,975,001 | $12,343,756 | 9.12% |
| Nextech Invest Ltd. | 2,329,480 | $14,559,250 | 6.08% |
| Ally Bridge Group (NY) LLC | 109,393 | $683,706 | 0.90% |
| Orbimed Advisors | 5,143,629 | $32,147,681 | 0.63% |
| RA Capital Management | 4,264,144 | $26,650,900 | 0.60% |
| Novo Holdings A/S | 815,707 | $5,098,169 | 0.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $3,112,506 | 0.33% |